Search

everythinglearnresearchcommunity

for

Search:↓

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Chemotherapy caused a woman's permanent hair loss and early menopause.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Kidney stones and hair loss are significantly related in people under 60 years old.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Barn owls with smaller black spots have higher testosterone levels, which might be due to genetic effects on hormone regulation rather than hormone effects on coloration.

Genes and hormones cause hair loss, with four genes contributing equally.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Women with idiopathic hirsutism and PCOS have higher RBP4 levels, and PCOS is linked to greater insulin resistance; weight management may help both conditions.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.